QTRX vs. TRNS, ALNT, EYPT, LAB, CTKB, SENS, QSI, AEHR, MASS, and FEIM
Should you be buying Quanterix stock or one of its competitors? The main competitors of Quanterix include Transcat (TRNS), Allient (ALNT), EyePoint Pharmaceuticals (EYPT), Standard BioTools (LAB), Cytek Biosciences (CTKB), Senseonics (SENS), Quantum-Si (QSI), Aehr Test Systems (AEHR), 908 Devices (MASS), and Frequency Electronics (FEIM). These companies are all part of the "measuring and control equipment" industry.
Quanterix vs. Its Competitors
Transcat (NASDAQ:TRNS) and Quanterix (NASDAQ:QTRX) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings, community ranking and risk.
Transcat has a net margin of 6.22% compared to Quanterix's net margin of -30.12%. Transcat's return on equity of 7.23% beat Quanterix's return on equity.
Quanterix received 61 more outperform votes than Transcat when rated by MarketBeat users. However, 65.84% of users gave Transcat an outperform vote while only 61.49% of users gave Quanterix an outperform vote.
98.3% of Transcat shares are owned by institutional investors. Comparatively, 86.5% of Quanterix shares are owned by institutional investors. 2.3% of Transcat shares are owned by insiders. Comparatively, 6.9% of Quanterix shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Transcat presently has a consensus price target of $114.00, suggesting a potential upside of 47.31%. Quanterix has a consensus price target of $15.60, suggesting a potential upside of 152.02%. Given Quanterix's higher probable upside, analysts clearly believe Quanterix is more favorable than Transcat.
In the previous week, Transcat had 2 more articles in the media than Quanterix. MarketBeat recorded 13 mentions for Transcat and 11 mentions for Quanterix. Quanterix's average media sentiment score of 1.56 beat Transcat's score of 0.15 indicating that Quanterix is being referred to more favorably in the news media.
Transcat has a beta of 0.75, suggesting that its stock price is 25% less volatile than the S&P 500. Comparatively, Quanterix has a beta of 1.05, suggesting that its stock price is 5% more volatile than the S&P 500.
Transcat has higher revenue and earnings than Quanterix. Quanterix is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.
Summary
Transcat beats Quanterix on 11 of the 17 factors compared between the two stocks.
Get Quanterix News Delivered to You Automatically
Sign up to receive the latest news and ratings for QTRX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding QTRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Quanterix Competitors List
Related Companies and Tools
This page (NASDAQ:QTRX) was last updated on 6/12/2025 by MarketBeat.com Staff
